SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Accera, Inc. Announces Peer-Reviewed Publication of the Results of its 90-Day Clinical Study of AC-1202 (Axona(TM) ) in Mild to Moderate Alzheimer's Disease